A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AOA / anaplastic oligoastrocytoma

[Related PubMed/MEDLINE]
Total Number of Papers: 50
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AOA  (>> Co-occurring Abbreviation)
Long Form:   anaplastic oligoastrocytoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI. AA, AO, EOR, IDH1, OS
2017 Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion. AOD, FISH, GBM-O, OA, OD, ODGs
2017 Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. AO, ASCT, HDC, OS, PFS, TMZ
2016 Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experience. AA, AO, EGFR, GBM-O, HGGs
2016 Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. AA, AO, ATRX, FFPE, OS, RFS
2015 Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components. GBM, Met, OC, PET
2015 Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. AA, AO, OS, PFS, RT
2015 Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12. PCV, RT, TMZ
2015 Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis. AOs, HGGs, OS, PFS
10  2015 Radiotherapy and temozolomide for anaplastic astrocytic gliomas. AA, RA
11  2014 1p/19q-driven prognostic molecular classification for high-grade oligodendroglial tumors. FISH, GBMO, HGOs, OS, PFS
12  2014 Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas. AA, AO, EORTC, IDH, OS, PCV, RCTs, RT, RTOG
13  2014 Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers. AO, IDH1, MGMT, OS, PCV, RT, TMZ
14  2014 Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted). AO
15  2014 KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas. CRM1, IDH1, KPNA2, LTS, OS, PFS
16  2014 Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution. GBM, GBMO, OS, PFS
17  2014 The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. AA, AO, GBM, OS, RT, SEER
18  2013 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas. AA, AO, OS, PFS
19  2013 ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. AA, ALT, AO, ATRX, IDH, MGMT
20  2013 Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. AO, HR, OS, PCV, RT
21  2013 Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma. AO, OS, PCV, PFS, TMZ
22  2013 [A molecular classification system for anaplastic glioma]. AA, AO, MGMT, OS, PFS, PFs
23  2012 Anaplastic glioma. AA, AE, AG, AO, RT, TMZ
24  2012 Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China. AO, LOH, OS
25  2012 Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas. AA, ATO, DL, DLT, MTD, RT, TMZ
26  2011 A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951. AOD, GBM
27  2011 Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. AA, alphaDC1, AO, GAA, GBM, IL
28  2011 The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma. GBM, GBM/OLIGO
29  2011 [Clinical trial updates for malignant brain tumors]. AA, AO, CNS, GBM, IFN-beta, TMZ
30  2010 Influence of histological subtype on survival after combined therapy of surgery and radiation in WHO grade 3 glioma. AA, AO, WHO
31  2009 Efficacy of temozolomide treatment in patients with high-grade glioma. AE, AO, GBM, GS, PD, PR, SD, TMZ
32  2009 Methylation Status of the O6-Methylguanine-Deoxyribonucleic Acid Methyltransferase Gene Promoter in World Health Organization Grade III Gliomas. AA, AO, MGMT, WHO
33  2009 MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. AA
34  2009 Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. amp, EGFR, EORTC, GBM
35  2009 [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors]. AO, OA, OT, TTP
36  2008 A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis. AO, APBPCR, CCNU, VOD
37  2008 Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas. AO, CISH, EGFR, GBM
38  2007 Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience. AMG, AO, MOA, OS
39  2007 Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. AOD
40  2007 Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade. AA, GBM
41  2006 Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. AO, MGMT, TMZ
42  2006 Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. AO, HR, PCV, RT
43  2006 Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. AO, FISH, OS
44  2003 Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. AA, AG, AO, PCV
45  2002 The expression of cell cycle regulatory proteins in oligodendroglial tumors. AO, LI, OA
46  2002 Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas. AA, CT, GBM, MRI
47  2001 Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. AO, OS, PCV, PFS
48  2000 Malignant gliomas. AA, AO, BCNU, CNS, GBM, PCV
49  1997 Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy. AA, AOD
50  1997 Distribution of endogenous tumour necrosis factor alpha in gliomas. AA, GB, OA, TNF-alpha